PREVENTION OF 5-FLUOROURACIL ASSOCIATED CARDIOTOXICITY

被引:3
|
作者
DAVIDSON, JA
机构
[1] Department of Respiratory Medicine, Advanced Trainee Medical Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia
来源
关键词
D O I
10.1111/j.1445-5994.1994.tb02187.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:321 / 321
页数:1
相关论文
共 50 条
  • [1] Symptomatic cardiotoxicity associated with 5-fluorouracil
    Meyer, CC
    Calis, KA
    Burke, LB
    Walawander, CA
    Grasela, TH
    [J]. PHARMACOTHERAPY, 1997, 17 (04): : 729 - 736
  • [2] CARDIOTOXICITY OF 5-FLUOROURACIL
    MAY, D
    WANDL, U
    BECHER, R
    NIEDERLE, N
    SCHMIDT, CG
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1990, 115 (16) : 618 - 621
  • [3] CARDIOTOXICITY OF 5-FLUOROURACIL
    GAMUCCI, T
    ZAMPA, G
    [J]. TUMORI, 1980, 66 (05) : 635 - 636
  • [4] 5-FLUOROURACIL CARDIOTOXICITY
    JAMESON, M
    THOMPSON, P
    HASTIE, B
    [J]. NEW ZEALAND MEDICAL JOURNAL, 1995, 108 (992) : 21 - 21
  • [5] CARDIOTOXICITY OF 5-FLUOROURACIL
    STEVENSON, DL
    MIKHAILIDIS, DP
    GILLETT, DS
    [J]. LANCET, 1977, 2 (8034): : 406 - 407
  • [6] CARDIOTOXICITY OF 5-FLUOROURACIL
    COLLINS, C
    WEIDEN, PL
    [J]. CANCER TREATMENT REPORTS, 1987, 71 (7-8): : 733 - 736
  • [7] Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine
    Jensen, SA
    Sorensen, JB
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (04) : 487 - 493
  • [8] Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine
    Søren Astrup Jensen
    Jens Benn Sørensen
    [J]. Cancer Chemotherapy and Pharmacology, 2006, 58 : 487 - 493
  • [9] THE SPECTRUM OF 5-FLUOROURACIL CARDIOTOXICITY
    MCLACHLAN, SA
    MILLWARD, MJ
    TONER, GC
    GUINEY, MJ
    BISHOP, JF
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1994, 161 (03) : 207 - 209
  • [10] The spectrum of 5-fluorouracil cardiotoxicity
    Dalzell, Jonathan R.
    Samuel, Leslie M.
    [J]. ANTI-CANCER DRUGS, 2009, 20 (01) : 79 - 80